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Although inflammatory cytokines induced by infection
or vaccination with adjuvants have long been known
to stimulate optimal antigen-presenting cell function,
recent evidence indicates that some inflammatory
cytokines also act directly on the responding T cells
to control their response to infection. Here, we review
the evidence that specific inflammatory cytokines act
to control the magnitude of expansion, the degree of
contraction, and the rate of memory cell development.
These data may suggest new strategies for manipulat-
ing vaccine efficacy in the quest to protect against
pathogenic microbes.
Introduction
CD8+ T cells recognize and respond to pathogen-
encoded peptides displayed by MHC class I molecules
on infected cells or on antigen-presenting cells (APCs).
Activated CD8+ T cells manifest an array of antimicrobial
effector pathways and molecules, which eliminate
infected cells by cytolysis or recruit and activate other
immune cells (Harty et al., 2000). CD8+ T cells are impor-
tant in defense against viruses, intracellular bacteria,
and protozoan pathogens and are also potentially
important in defense against malignancy. Thus, patho-
gen-specific CD8+ T cell responses are an important
goal of vaccination.
The CD8+ T cell response can be divided into four rel-
atively distinct phases (Figure 1). Initial activation (phase
1) is critically dependent on relatively stable interactions
between naive T cells and mature, antigen (Ag) and cos-
timulatory molecule-expressing dendritic cells (DCs)
(Lanzavecchia and Sallusto, 2001). The subsequent pro-
liferative (expansion) phase lasts 5–8 days, during which
Ag-specific CD8+ T cell numbers may increase by
>10,000-fold (Badovinac and Harty, 2002; Kaech et al.,
2002b). Clonal expansion is also associated with differ-
entiation to effector T cells that migrate throughout the
body to defend against infection (Weninger et al.,
2002). The third phase involves a contraction in number
where 90%–95% of effector cells are eliminated over the
ensuing week (Badovinac and Harty, 2002; Sprent and
Tough, 2001), and the final phase is the initiation and
maintenance of the memory CD8+ T cell pool by the cells
surviving contraction (Kaech et al., 2002b). Several stud-
ies collectively indicate that the expansion, contraction,
and memory phases of the CD8+ T cell response are
largely if not completely independent of continued Ag
display, suggesting that a relatively brief encounter
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CD8+ T cell differentiation (Badovinac et al., 2002; Kaech
and Ahmed, 2001; Mercado et al., 2000; van Stipdonk
et al., 2001). However, it has become clear that, in addi-
tion to Ag, a variety of signals must be integrated by the
responding T cells to generate optimal responses and
ensure proper regulation of T cell homeostasis. Here,
we discuss the evidence that inflammatory cytokines,
stimulated by infection or vaccination with strong adju-
vants, provide important signals that directly shape
the Ag-specific CD8+ T cell response.
Inflammatory Cytokines Regulate T Cell Expansion
CD8+ T cells specific for any one peptide constitute
a small fraction of the naive repertoire. This population
must greatly expand in numbers to effectively combat
rapidly replicating pathogens. In addition, the size of
the memory CD8+ T cell pool, which provides protection
against future exposure to the same pathogen, is di-
rectly proportional to the size of the effector T cell pool
generated after primary infection or vaccination (Maso-
pust and Ahmed, 2004). However, whereas experimen-
tal infections of mice generate robust expansion in the
numbers of Ag-specific effector cells, subunit vaccines
are generally less effective even when delivered with ad-
juvants (Levine and Sztein, 2004; Zinkernagel, 2003). Al-
though the amount of Ag will always be an important
consideration in the magnitude of the response to vacci-
nation, these observations also suggest that the inflam-
matory milieu stimulated by infection contributes to
robust expansion in Ag-specific CD8+ T cell numbers.
Proinflammatory cytokines elicited in response to in-
fection have immediate effects on cells to promote early
control of pathogen replication. Furthermore, inflamma-
tory cytokines stimulated through microbial pattern
recognition receptors (PRR) participate in generation
of potent APCs to prime T cell responses. Indeed, the
current paradigm is that successful vaccination de-
pends on strong adjuvants to activate inflammation
and APCs. These issues have been extensively reviewed
(Castellino and Germain, 2006; Heath and Carbone,
2001; Steinman, 2003), and we will not deal further
with the role of inflammation in APC biology. Instead, it
has become increasing clear that T cells also receive
signals from inflammatory cytokines, which determine
the extent of their proliferation, survival, and ability to
develop effector functions. To date, the cytokines iden-
tified that can provide this signal 3 for optimal CD8+
T cell expansion are interleukin-12 (IL-12), type I inter-
ferons (IFN-ab), and type II interferon (IFN-g).
IL-12 as Signal 3
IL-12 is produced by DCs and other cells after some, but
not all, infections and is an important mediator of Th1 po-
larization of CD4+ T cells (Murphy et al., 2000). IL-12 can
also act synergistically with IL-18 to induce Ag-indepen-
dent IFN-g production by memory phenotype CD8+
T cells (Beadling and Slifka, 2005; Berg et al., 2003; Lert-
memongkolchai et al., 2001). In addition, IL-12 can act di-
rectly on CD8+ T cells in vitro and in vivo to promote
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20Figure 1. Naive-to-Memory CD8+ T Cell Progression after Acute Infection or Vaccination
Antigenic peptides presented by mature dendritic cells (DCs) to naive CD8+ T cells trigger expansion and differentiation into effector CD8+ T cells.
Five to ten percent of CD8+ T cells detected at the peak of expansion survive the contraction phase to initiate the memory pool, which can remain
stable in number for life. LOD represents limit of detection.proliferation, survival, and differentiation into effector
cells capable of cytolysis (Curtsinger et al., 1999;
Schmidt and Mescher, 1999). When CD8+ T cells are ex-
posed to IL-12 together with peptide-MHC and signal 2
(provided by either CD28-B7 interactions or IL-2), their
ability to proliferate, survive, and kill is markedly en-
hanced compared to T cells in the absence of IL-12 (Curt-
singer et al., 1999; Schmidt and Mescher, 1999, 2002).
The timing of exposure to IL-12 is critical for optimal
effector CD8+ T cell generation (Curtsinger et al.,
2003). IL-12 functions best when CD8+ T cells are ex-
posed to peptide-MHC, signal 2, and IL-12 continuously
from the onset of activation. However, IL-12 can be
added as late as 18 hr in vitro and 24 hr in vivo after
CD8+ T cell activation and still positively influence prolif-
eration and survival of T cells. IL-12 may promote the
survival of activated T cells by upregulation of the antia-
poptotic protein Bcl-3 (Valenzuela et al., 2005) and/or by
inhibiting activation of the proapoptotic enzyme cas-
pase-3 (Palmer et al., 2001).
Accumulating evidence supports a direct role for IL-12
in facilitating optimal CD8+ T cell responses in vivo. For
example, IL-12 functions as well as complete Freund’s
adjuvant (CFA) in promoting full activation of CD8+ T cells
in an in vivo model of peptide immunization (Schmidt and
Mescher, 1999). Interestingly, IL-12 promotes the pep-
tide-stimulated response of wild-type CD8+ T cells that
were placed in IL-12Rb1-deficient mice (Schmidt and
Mescher, 2002), suggesting a direct interaction of IL-12
with the responding T cells. Consistent with this idea,TCR-transgenic (TCR-tg) CD8+ T cells lacking both the
IL-12 and IFN-ab receptors undergo reduced in vivo
expansion and differentiation compared to wild-type
cells after Listeria monocytogenes infection (Z. Xiao
and M. Meschser, personal communication). However,
IL-12p35-deficient mice are capable of generating Ag-
specific CD8+ T cell responses after lymphocytic chorio-
meningitis virus (LCMV) infection (Cousens et al., 1999).
These data suggest that other cytokines may function
as signal 3 for CD8+ T cell responses and that pathogen
biology may dictate which cytokines are essential.
IFN-ab as Signal 3
Marrack and colleagues identified IFN-ab as capable of
directly supporting the in vitro survival of in vivo-acti-
vated CD4+ and CD8+ T cells via a mechanism that
does not involve upregulation of the antiapoptotic mole-
cules Bcl-2 or Bcl-XL (Marrack et al., 1999). IFN-a is also
capable of promoting optimal CD8+ T cell expansion and
development of lytic capabilities after in vitro activation
with peptide-MHC and B7.1, suggesting that IFN-ab
can function as signal 3 (Curtsinger et al., 2005). In con-
trast to these in vitro studies, the role of IFN-ab in
promoting the expansion of Ag-specific CD8+ T cells in
vivo after infection is less clear. Nearly normal expansion
of Ag-specific CD8+ T cells occurs following LCMV infec-
tion of IFN-abR-deficient mice compared to wild-type
mice (Cousens et al., 1999; Ou et al., 2001), although
the proportions of Ag-specific CD8+ T cells generated
to each epitope in the IFN-abR-deficient mice are altered
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these early results, IFN-abR-deficient P14 TCR-tg
CD8+ T cells adoptively transferred into wild-type hosts
exhibit a severe defect in their ability to expand and gen-
erate memory populations after LCMV infection (Aichele
et al., 2006; Kolumam et al., 2005). The small number of
memory cells generated are maintained for at least 140
days after infection, indicating that the activity of IFN-
ab is important for optimal T cell expansion, not in the
maintenance of memory CD8+ T cells (Kolumam et al.,
2005). IFN-abR-deficient CD8+ T cells demonstrate equal
or greater rates of division compared to wild-type cells
after LCMV infection; however, the IFN-abR-deficient
CD8+ T cells fail to accumulate, indicating a deficiency
in survival of these cells in the absence of IFN-ab signal-
ing (Aichele et al., 2006; Kolumam et al., 2005). In addi-
tion, recent studies show that IFN-abR-deficient TCR-
tg CD4+ T cells adoptively transferred into wild-type
mice expand >99% less than wild-type tg T cells after
LCMV infection (Havenar-Daughton et al., 2006). These
data strongly argue that direct IFN-abR signals received
by T cells serve as a critical signal 3 after LCMV infection.
Although the discrepancy between the seemingly nor-
mal expansion after LCMV infection of IFN-abR-deficient
mice and the reduced expansion of IFN-abR-deficient
T cells has not been formally resolved, the high-level
and protracted LCMV infection observed in the IFN-
abR-deficient mice (Cousens et al., 1999) is a potentially
important variable between the experimental systems.
However, there are a number of infectious model sys-
tems where IFN-ab signaling is dispensable for the ex-
pansion of Ag-specific T cells. IFN-abR-deficient P14
TCR-tg CD8+ T cells exhibit only a modest defect in ex-
pansion and survival after infection with recombinant
vaccinia virus expressing the LCMV glycoprotein
(Aichele et al., 2006). Similarly, IFN-ab signaling is not re-
quired for the expansion of OT-II TCR-tg CD4+ T cells
(Havenar-Daughton et al., 2006), OT-1 TCR-tg CD8+
T cells (Z. Xiao and M. Mescher, personal communica-
tion), or endogenous OVA257–264-specific CD8
+ T cells
(A. Jabbari, V.P.B., and J.T.H., unpublished data) after in-
fection with L. monocytogenes expressing ovalbumin.
To directly test the dependence on IFN-ab for signal 3
during different infections, adoptively transferred wild-
type and IFN-abR-deficient OT-1 TCR-tg CD8+ T cells
were primed with OVA-coated DCs (controlled amount
of Ag) at the same time that the recipient mice were
infected with LCMV, vaccinia virus, vesicular stomatitis
virus, or L. monocytogenes to induce inflammation.
Wild-type cells expanded equally well after DC-peptide
priming in the presence of all four types of infections, in-
dicating that all of the infections tested generated one or
more cytokines that could provide signal 3 to responding
CD8+ T cells. IFN-abR-deficient CD8+ T cells exhibited
the greatest defect in expansion when primed during
LCMV infection, highlighting the dependence of CD8+ T
cells on IFN-ab for signal 3 during this infection (Thomp-
son et al., 2006). These data further illustrate that patho-
gen biology is most likely critical in determining the
specific requirement for signal 3 by Ag-specific T cells.
IFN-g as Signal 3
IFN-g is also able to promote optimal expansion of Ag-
specific T cell populations after LCMV infection (Badovi-nac et al., 2000; Whitmire et al., 2005a, 2005b) or peptide
immunization (Sercan et al., 2006). Reduced expansion
of IFN-gR1-deficient cells compared to wild-type P14
TCR-tg CD8+ T cells in the same host after LCMV infec-
tion indicates that IFN-g acts directly on the responding
CD8+ T cells to promote their expansion (Whitmire et al.,
2005b). Similarly, IFN-gR1-deficient CD4+ TCR-tg cells
fail to expand normally after LCMV infection (Whitmire
et al., 2005a). In a separate study, wild-type CD8+ T cells
transferred into IFN-g-deficient mice expanded 80%
less than cells transferred into wild-type mice after im-
munization with peptide plus LPS (Sercan et al., 2006).
However, similar to what has been observed with mice
and T cells lacking IFN-abR, expansion of L. monocyto-
genes-specific CD4+ and CD8+ T cells in mice lacking
IFN-g or the IFN-gR1 is equal or greater than in wild-
type mice, indicating that IFN-g signaling in Ag-specific
T cells is not required for expansion and that some other
cytokine is capable of providing signal 3 to responding
T cells after L. monocytogenes infection (Badovinac
et al., 2000; J.S.H. and J.T.H., unpublished data).
Why Can So Many Inflammatory Cytokines Serve
as Signal 3?
The collective theme is that a third signal delivered to
Ag-specific T cells, in addition to peptide-MHC and sig-
nal 2, is required to promote optimal clonal expansion,
perhaps by increasing survival of effector cells (Figure 2).
This signal is not limited to one cytokine but can be de-
livered by at least three candidate cytokines in vitro and
in vivo. The puzzle remaining is why optimal T cell ex-
pansion and survival is dependent on variable sources
of signal 3 after different types of infection. Viruses, bac-
teria, and protozoan pathogens will likely activate a non-
overlapping spectrum of PRR, leading to unique pat-
terns of inflammation. For instance, large amounts of
IFN-ab are produced after LCMV infection, but virtually
no IL-12 can be detected (Cousens et al., 1997; Orange
and Biron, 1996; Welsh, 1978). In contrast, IFN-b mRNA
is modestly upregulated (J.S.H. and J.T.H., unpublished
data) but IL-12 protein (Auerbuch et al., 2004) and large
amounts of IFN-g mRNA and protein are produced after
L. monocytogenes infection (Haring et al., 2005; Poston
and Kurlander, 1991, 1992). In addition, the target cells
and the outcome of infection (lytic for L. monocytogenes
versus nonlytic for LCMV) may influence the nature of
the inflammatory response. Thus, the combination of
cellular responses to each pathogen most likely trans-
lates into a unique pattern of inflammation that dictates
which cytokine provides the essential signal 3 required
for optimal T cell responses.
The timing of cytokine signaling required for optimal
expansion and survival is an additional area of interest.
IL-12 functions best when T cells are continuously ex-
posed to the cytokine in vitro but can be added to T cells
at later times and still improve their ability to kill targets
(Curtsinger et al., 2003). In mice or cells lacking IFN-ab or
IFN-g receptors, the T cells are without signals from
these cytokines throughout the expansion phase. Be-
cause T cells lacking the IFN-abR divide but fail to sur-
vive (Kolumam et al., 2005), this suggests that IFN-ab
may be required postpriming to stimulate survival of
the proliferating T cells. In support of this idea, Ag-spe-
cific CD8+ T cells moderately downregulate mRNA for
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22Figure 2. Signal 3 Is Required for Optimal CD8+ T Cell Clonal Expansion and Survival
Maximal expansion, function, and survival of effector CD8+ T cells depend on the action of cytokines that are shown to act as signal 3 during the
early stages of the CD8+ T cell response. Although multiple cytokines (IL-12, type I IFNs, and IFN-g) can serve as signal 3 for optimal CD8+ T cells
in vitro, in vivo studies suggest that signal 3 after infection may be pathogen dependent.both chains of the IFN-ab receptor very early after infec-
tion with L. monocytogenes, but expression of both
receptor chains is back to naive levels by 3 days after
infection and remains stable throughout the expansion
phase (J.S.H. and J.T.H., unpublished data).
In contrast, there is evidence that stimulatory IFN-g
signals may be required very early during the CD8+
T cell response. Ag-specific CD8+ T cells receive IFN-g
signals within 12 hr after infection with L. monocyto-
genes and then lose their responsiveness to IFN-g via
downregulation of IFN-gR2 until the end of their expan-
sion phase (Haring et al., 2005). Thus, any positive effect
that IFN-g can have on the expansion of CD8+ T cells
must be proximal to priming. Later during expansion, it
may be important for T cells to evade signals delivered
by IFN-g in order to avoid the proapoptotic effects of
this cytokine (Boehm et al., 1997; Refaeli et al., 2002).
In summary, although multiple cytokines can serve as
signal 3 for optimal CD8+ T cell responses in vitro, the re-
quirement for individual, pathogen-specific signal 3 is
apparent after in vivo infection. Understanding the fac-
tors that determine which cytokines function as signal
3 during immune responses to infection will likely require
a systems approach to analyze the complex interplay
of inflammation and the responding CD8+ T cells after
diverse infections. Furthermore, additional studies are
necessary to fully determine the signal 3 requirements
by responding CD4+ T cells that are necessary after
different infections for optimal expansion and differenti-
ation into memory CD4+ T cells. This information is likely
to be critical in the choice of adjuvants to optimize both
CD4+ and CD8+ T cell responses to vaccination.
Inflammatory Cytokines and T Cell Contraction
The expansion phase of Ag-specific CD8+ T cells is fol-
lowed by an equally abrupt contraction phase, where
90%–95% of Ag-specific CD8+ T cells are eliminated.
This substantial yet incomplete downsizing ensures
that space and resources are available for CD8+ T cell re-
sponses against new pathogens while also maintaining
a heightened ability to respond against previously en-
countered pathogens (memory). Although early models
suggested that contraction is induced via activation-
induced cell death (AICD), subsequent studies demon-
strated normal contraction of Ag-specific CD8+ T cellslacking the death receptors (CD95 and TNFRI) implicated
in classical AICD (Nguyen et al., 2000; Reich et al., 2000).
More recent investigations have focused on regulation of
pro- and antiapoptotic Bcl-2 family members, perhaps
through modulation of common gamma-chain-utilizing
cytokine receptors such as the IL-7R. For example, dele-
tion of the BH3-only Bcl-2 family member Bim prevents
the massive apoptosis of T cells observed after in vivo
superantigen challenge (Hildeman et al., 2002) and also
ameliorates contraction after HSV infection (Pellegrini
et al., 2003). Although initial results revealed an excellent
correlation between the fraction of IL-7R-expressing
CD8+ T cells at the peak of expansion and the number
of Ag-specific CD8+ T cells that survive contraction (Ba-
dovinac et al., 2004; Huster et al., 2004; Kaech et al.,
2003), other studies demonstrate that expression of the
IL-7R is not sufficient to prevent contraction under less
inflammatory circumstances (Badovinac et al., 2005; La-
combe et al., 2005). Thus, the signals that regulate death
of most, but not all, T cells present at the peak of the
response and the precise death pathways involved
remain to be elucidated.
After acute infection, the onset of the contraction
phase generally starts as the pathogen is cleared. This
correlation implies that the onset of CD8+ T cell contrac-
tion is regulated by somehow ‘‘sensing’’ the clearance of
infection. In contrast to this notion, experiments over the
last several years demonstrate that the onset and de-
gree of contraction are independent of the magnitude
of Ag-specific CD8+ T cell expansion, as well as the
dose and duration of infection (Badovinac et al., 2002;
Wherry et al., 2003a). These results suggest that early
events after infection are also critical for ‘‘programming’’
CD8+ T cell contraction. Paradoxically, at least one of
the inflammatory cytokines (i.e., IFN-g) that regulate
the expansion phase also influences the onset and de-
gree of T cell contraction.
A substantial reduction in Ag-specific CD8+ T cell con-
traction occurs in mice lacking IFN-g after infection with
attenuated L. monocytogenes and LCMV (Badovinac
et al., 2000). Ag-specific CD8+ T cell numbers remain ele-
vated in IFN-g-deficient mice for at least one year after
L. monocytogenes or LCMV infection (Badovinac et al.,
2000; unpublished data). Reduced contraction is still ob-
served when IFN-g-deficient mice are treated with
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L. monocytogenes infection (Badovinac et al., 2004),
demonstrating that prolonged infection does not
account for decreased CD8+ T cell contraction in the
absence of IFN-g. Therefore, IFN-g influences the degree
of contraction of CD8+ T cell responses after infection
(Figure 3).
Expansion of Ag-specific CD8+ T cells in IFN-g-defi-
cient mice is normal or even enhanced depending on
the epitope evaluated after attenuated L. monocyto-
genes infection but is reduced after LCMV infection (Ba-
dovinac et al., 2000). These experiments raise the inter-
esting question of whether contraction is directly linked
to the degree of expansion or is required for memory
CD8+ T cell generation. Pretreatment of wild-type mice
with antibiotics prior to attenuated L. monocytogenes
infection allows the generation of fully functional CD8+
T cell memory in the absence of contraction (Badovinac
et al., 2004). Inflammatory cytokines including IFN-g are
greatly reduced in the antibiotic-pretreated mice, and,
consistent with a role for inflammation in regulating ex-
pansion, the magnitude of the CD8+ T cell response is
also diminished (Figure 3). However, injection of CpG
ODN to induce inflammation (including IFN-g secretion)
in the antibiotic-pretreated mice restores contraction
without altering the magnitude of expansion. Together,
these data suggest that inflammatory signals, rather
than the magnitude of expansion, regulate CD8+ T cell
contraction. In addition, these experiments demon-
strate that contraction is not required for the generation
of functional CD8+ T cell memory.
As discussed previously, IFN-g mRNA and protein are
markedly upregulated for 1–2 days after L. monocyto-
genes infection and then return to baseline. Consistent
with this timing, Ag-specific CD8+ T cells receive IFN-g
signals within 12 hr after infection and then become re-
fractory to further signaling by downregulating IFN-
gR2 during the expansion phase (Haring et al., 2005).
The fraction of Ag-specific CD8+ T cells that regain re-
sponsiveness to IFN-g signals actually increases during
contraction, an observation that is not consistent with
the ability of this cytokine to directly kill effector cells.
This hypothesis is further supported by the absence of
IFN-g mRNA in the spleen or IFN-g protein in the serum
during contraction (Haring et al., 2005). Although space
limitations preclude a detailed discussion here, several
studies suggest that IFN-g also regulates contraction
of Ag-specific CD4+ T cells (Chu et al., 2000; Dalton
et al., 2000; J.S.H. and J.T.H., unpublished data). To-
gether, these data suggest that IFN-g signals delivered
to responding T cells early after infection will influence
the contraction program, as well as the expansion pro-
gram, of CD8+ T cell responses. Thus, IFN-g appears
to play a pivotal role in CD8+ T cell homeostasis, with
the capacity to enhance effector cell numbers and func-
tion but also to ensure appropriate contraction of these
Ag-specific populations. The challenge is to identify the
molecular pathways initiated by IFN-g in T cells within
hours after infection to regulate the contraction of Ag-
specific T cells after many rounds of division.
CD8+ T Cell Memory
The 5%–10% of effector CD8+ T cells that survive the
contraction phase initiate the memory pool, which canremain stable in number for life (Kaech et al., 2002b).
However, memory CD8+ T cell maintenance is a dynamic
process consisting of homeostatic proliferation that is
balanced by death and involves changes in phenotype
that may further shape the function, distribution, and
per-cell protective capacity of memory CD8+ T cell pop-
ulations (Masopust et al., 2001; Sallusto et al., 1999; We-
ninger et al., 2001). Due to their increased numbers,
higher functional avidity, and lower signaling threshold
required for reactivation, memory CD8+ T cells respond
faster than their Ag-inexperienced naive counterparts
and are able to provide heightened immunity after rein-
fection (Bachmann et al., 1999; Bertram et al., 2004;
Kersh et al., 2003; Slifka and Whitton, 2001). In addition,
memory CD8+ T cells are able to go through a second
round of Ag-driven expansion that will result, depending
on the dose of secondary challenge, in a further increase
in memory CD8+ T cell numbers (Kaech et al., 2002b;
Masopust and Ahmed, 2004). This latter property is crit-
ical for the success of prime-boost vaccination regi-
mens (Woodland, 2004).
Even many weeks after initial stimulation, memory
CD8+ T cells do not display a uniform phenotype, but
they can be divided based on expression of surface
markers into numerous subpopulations (for example,
‘‘effector memory’’ and ‘‘central memory’’; Masopust
et al., 2001; Sallusto et al., 1999) that differ in their ana-
tomical distribution and ability to protect depending on
the nature and route of infection (Roberts et al., 2005; Un-
soeld et al., 2002; Wherry et al., 2003b). Some, but not all,
markers that are used to distinguish Ag-experienced
memory CD8+ T cells are also expressed on naive and/
or effector CD8+ T cells. Furthermore, some of the key
Figure 3. Modulation of CD8+ T Cell Expansion and Contraction
Phases by IFN-g
Normal expansion but reduced contraction of Ag-specific CD4+ and
CD8+ T cells is observed after infection of IFN-g-deficient mice with
attenuated L. monocytogenes (IFN-g-deficient; red line) compared
to the severe contraction of CD8+ T cell responses in wild-type hosts
(WT; black line). Antibiotic (Abx) pretreatment of IFN-g-sufficient
wild-type mice (Abx WT; blue line) before L. monocytogenes infec-
tion results in reduced expansion but no contraction of CD8+ T cells
as well as substantially decreased levels of IFN-g early after bacte-
rial challenge.
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guish primary ‘‘central memory’’ from effector and ‘‘ef-
fector memory’’ CD8+ T cells are downregulated on
long-term secondary memory CD8+ T cells. However,
we recently showed that, despite displaying a phenotype
that is associated with impaired memory, secondary
memory CD8+ T cells are able to provide better per-cell
protective immunity and undergo expansion in numbers
similar to primary memory cells after reinfection (Jabbari
and Harty, 2006). Thus, identification of memory CD8+ T
cells based on phenotype is problematic without precise
knowledge of their Ag-exposure history. Although the
heterogeneity in memory cell phenotype is daunting, ad-
ditional studies to elicit the relationships between mem-
ory CD8+ T cell phenotype and function are warranted
because this information may help tailor vaccine strate-
gies to provide the most robust protection against spe-
cific pathogens. Finally, it should be remembered that
the ‘‘noise’’ imprinted in the phenotype of memory
CD8+ T cells likely represents an evolutionary strategy
to maximize anatomical coverage and maintain readi-
ness to defend against the widest range of pathogens.
Because the relationships between memory cell phe-
notype and function remain unclear, we prefer to define
‘‘good’’ memory CD8+ T cells based on their ability to (1)
persist, (2) protect, (3) undergo vigorous expansion in
response to pathogen rechallenge, and (4) generate
higher numbers of memory cells after booster immuni-
zation. Next we will discuss recent evidence that inflam-
matory cytokines regulate the rate at which CD8+ T cells
acquire memory characteristics and how vaccination
can be manipulated to accelerate generation of Ag-spe-
cific CD8+ T cells that can respond to booster immuniza-
tion within days of the initial stimulation.
Rate of Memory CD8+ T Cell Generation
after Acute Infection
Over the last several years, it has become apparent that
differentiation of naive to functional memory CD8+ T cells
is the result of a program that is largely, although not ex-
clusively, set in motion by early events after infection or
vaccination (Badovinac et al., 2002; Kaech and Ahmed,
2001; Mercado et al., 2000; van Stipdonk et al., 2001;
Wong and Pamer, 2001). This program is initiated by ma-
ture DCs that display pathogen-derived Ag and deliver
costimulatory signals to T cells. Although not addressed
in detail here, inflammation generated by infection clearly
contributes to optimal maturation of DCs (Castellino and
Germain, 2006; Heath and Carbone, 2001; Steinman,
2003). In addition, signals from other cell types such as
CD4+ T cells may be essential to generate the most robust
CD8+ T cell memory after vaccination and some infec-
tions (Bevan, 2004; Janssen et al., 2005; Shedlock and
Shen, 2003; Sun and Bevan, 2003; Sun et al., 2004). Fi-
nally, the ability to express CD25, the high-affinity IL-2R,
during CD8+ T cell priming is critical for secondary
CD8+ T cell responses (Williams et al., 2006). Together,
these data suggest that the program leading to CD8+
T cell memory is complex and dependent on the integra-
tion of multiple signals by the responding CD8+ T cells.
Ag-independent, functional CD8+ T cell memory popu-
lations are formed after acute infections. Successful
clearance of infection and the resulting Ag-free environ-
ment may be required for development of fully functionalmemory CD8+ T cells (Wherry and Ahmed, 2004). How-
ever, the acquisition of memory CD8+ T cell characteris-
tics, including the ability to vigorously respond to booster
immunizations, by the populations of Ag-specific CD8+
T cells takes a month or more after clearance of acute in-
fection (Kaech et al., 2002a) (Figure 4A). Although the
cells that will survive contraction and seed the memory
pool (memory precursors) may already be present at
the peak of expansion, their ability to respond vigorously
to booster immunization is likely masked by the numeri-
cally superior effector CD8+ T cell pool (Badovinac
et al., 2005; Wong et al., 2004). However, even after elim-
ination of the effector pool by contraction, early memory
CD8+ T cells do not exhibit the same capacity to undergo
secondary expansion as late memory populations
(Kaech et al., 2003; V.P.B. and J.T.H., unpublished data).
Understanding why CD8+ T cells need time to develop
‘‘good’’ memory characteristics and whether this inter-
val can be manipulated may be important in the design
of optimal prime-boost vaccination protocols. Experi-
ments from several systems suggest that the rate at
which CD8+ T cells acquire memory characteristics
may not be fixed. Reducing the stimulation of CD8+
T cells during infection with intracellular pathogens
facilitates differentiation primarily into a CD62Lhi subset
(van Faassen et al., 2005). Similarly, the conversion from
CD62Llo to CD62Lhi memory CD8+ T cells is faster after
low-dose than high-dose L. monocytogenes infection
(Wherry et al., 2003b). Decreasing the duration of
L. monocytogenes infection by antibiotic treatment 24
to 48 hr after infection has minimal impact on expansion,
contraction, and memory of Ag-specific CD8+ T cell
numbers (Badovinac et al., 2002; Mercado et al., 2000).
Interestingly, early termination of infection by antibiotic
treatment results in a modest increase in the frequency
of IL-2-producing memory CD8+ T cells (Badovinac
et al., 2004; Williams et al., 2006). More recent studies
show that progression to a CD8+ T cell memory pheno-
type (CD127hi, CD43lo, CD27hi, IL-2 producing) is accel-
erated in antibiotic-treated compared to control-
infected mice, as is the ability to proliferate in response
to secondary L. monocytogenes booster immunization
(V.P.B. and J.T.H., unpublished data). Therefore, manip-
ulations to decrease the duration of infection in vivo may
facilitate memory CD8+ T cell differentiation.
The time needed for CD8+ T cells to develop memory
characteristics could be controlled by Ag display and/
or inflammation, both of which are transient after acute
infection (Figure 4A). Antibiotic treatment after L. mono-
cytogenes infection diminishes both inflammatory
cytokine (IFN-g and TNF) production and the duration
of Ag display (Badovinac et al., 2002; Mercado et al.,
2000). Importantly, injection of CpG ODN to restore in-
flammation (Krieg, 2003; Takeda et al., 2003) in the anti-
biotic-treated mice prevents the rapid generation of
memory phenotype CD8+ T cells and the ability to ex-
pand to secondary Ag challenge without changing the
magnitude of expansion, contraction, or early memory
cell numbers (V.P.B. and J.T.H., unpublished data). Fur-
thermore, as discussed in the last section, pretreatment
of mice with antibiotics followed by L. monocytogenes
infection results in a 99.99% decrease in bacterial load
at 24 hr after infection, diminishes IFN-g production,
and markedly impairs Ag-specific CD8+ T cell
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T Cell Differentiation to Memory
(A) Depending on the nature of infection
(chronic versus acute) or immunization (pep-
tide-DC), CD8+ T cells exhibit differential pro-
gression to memory that depends on the de-
gree and duration of infection and
inflammation. During chronic infections,
CD8+ T cells never attain all of the phenotypic
and functional characteristics of long-term
memory, while successful clearance of the
pathogen after acute infections enables
slow progression to fully functional CD8+ T
cell memory. Naive CD8+ T cell activation af-
ter peptide-DC immunization occurs in the
absence of infection or inflammation, and
progression to CD8+ T cell memory is accel-
erated.
(B) Model: The rate of memory CD8+ T cell dif-
ferentiation is influenced by the presence or
absence of inflammatory stimuli received by
responding CD8+ T cells.expansion. Follow-up studies reveal that CD8+ T cells
primed in antibiotic-pretreated mice develop pheno-
typic (CD127hi, CD27hi, CD43lo) and functional (IL-2 pro-
duction and vigorous proliferation after secondary
challenge) characteristics of long-term memory CD8+
T cells within one week after immunization (V.P.B. and
J.T.H., unpublished data). This accelerated generation
of CD8+ T cells with memory characteristics correlates
with substantially decreased amounts of proinflamma-
tory cytokines and chemokines (IFN-g, TNF, IL-6, IL-
12, IL-10, RANTES, MIP-1a, G-CSF) during the first 24
hr after infection compared to control-infected mice
(Badovinac et al., 2004; V.P.B. and J.T.H., unpublished
data). Although it remains unknown how DCs receive
maturation signals in the absence of inflammatory cyto-
kines, these data suggest that the extent and duration of
infection-induced inflammation influence the rate of
memory CD8+ T cell generation (Ahmed and Gray,
1996; Masopust et al., 2004).
CD8+ T Cell Memory after DC Immunization
Immunization with in vitro-matured peptide-loaded DCs
provides a setting where CD8+ T cells receive the fullcomplement of mature DC-mediated signals in the ab-
sence of infection- or adjuvant-induced inflammation
(Hamilton and Harty, 2002). Consistent with the idea
that inflammation influences the rate of memory CD8+
T cell generation, we observe rapid differentiation of
CD8+ T cells from naive to effector to memory after im-
munization of mice with in vitro-matured peptide-loaded
DCs (Badovinac et al., 2005). As early as 4 to 6 days after
peptide-DC immunization, the majority of Ag-specific
CD8+ T cells express markers (CD127hi, CD27hi,
CD43lo, IL-2 production) of long-term memory. These
early memory cells are able to vigorously proliferate in
response to a variety of booster regimens, leading to
a rapid elevation in the numbers of secondary effector
CD8+ T cells, substantially elevated secondary memory
cell numbers, and enhanced protective immunity. DC
immunization does not evoke systemic production of in-
flammatory cytokines and also results in a relatively
short window of ‘‘functional’’ Ag presentation as de-
tected by proliferation of injected ‘‘sensor’’ naive TCR-
tg T cells. Coinfection of mice with L. monocytogenes
or CpG ODN treatment to induce inflammation prevents
the accelerated naive-to-memory CD8+ T cell transition
Immunity
26after peptide-DC immunization without changing the
magnitude of Ag-specific CD8+ T cell expansion. These
data strongly argue that it is inflammation and not the
duration of Ag display that regulates the rate at which
CD8+ T cells acquire memory characteristics (Figure 4A).
Understanding how inflammation controls the rate of
memory CD8+ T cell generation will require knowledge
of the specific cytokines involved and whether these
cytokines are (1) acting on DCs to control programming
signals delivered to the CD8+ T cells, (2) acting directly
on the responding CD8+ T cells, or (3) acting indirectly
via other cell types. Several experiments suggest that in-
flammation might act on the responding CD8+ T cell
populations (Badovinac et al., 2005) (Figure 4B). Accel-
erated memory CD8+ T cell differentiation occurs when
CpG ODN is used for in vitro maturation of DCs. In con-
trast, CpG ODN treatment in vivo prevents the genera-
tion of early memory CD8+ T cells without altering the
lifespan of injected DCs, the duration of functional Ag
presentation, or the magnitude of CD8+ T cell expansion
in vivo. Treatment with CpG ODN as late as three days
after DC immunization, a time when DC-mediated Ag
presentation is undetectable, still prevents early acqui-
sition of memory characteristics by responding CD8+
T cells, suggesting that CpG ODN (or CpG-induced
inflammation) is not acting through the injected DCs.
Importantly, CpG ODN treatment at the time of DC
immunization does not prevent rapid memory CD8+
T cell generation in IFN-gR2-deficient mice. These data
suggest that IFN-g-mediated signals received by re-
sponding CD8+ T cells shortly after immunization play
an important role in controlling the rate of memory
CD8+ T cell differentiation. Together, these studies sug-
gest that vaccination strategies that allow maturation of
DCs but limit inflammatory signals such as IFN-g to the
responding T cells may facilitate progression to ‘‘good’’
memory and decrease the interval required for increas-
ing Ag-specific CD8+ T cell effector and memory num-
bers by booster immunization.
Inefficient Memory CD8+ T Cell Generation after
Chronic Infections
Acute infections and DC immunization both generate
‘‘good’’ memory CD8+ T cell populations, although at
different rates. In contrast, multiple studies show that
chronic infections lead to inefficient or poor-quality
CD8+ T cell memory (Klenerman and Hill, 2005; Wherry
et al., 2004) (Figure 4A). CD8+ T cells at late time points
in chronically infected mice are ‘‘exhausted’’ (deleted
or functionally impaired) and are unable to provide ster-
ilizing immunity (Moskophidis et al., 1993; Wherry et al.,
2003a; Zajac et al., 1998). In addition, memory CD8+
T cells from chronically infected mice cannot persist af-
ter transfer to an Ag-free environment, partly due to their
inability to undergo IL-7- and IL-15-driven homeostatic
proliferation (Klenerman and Hill, 2005; Wherry et al.,
2004). Memory CD8+ T cells from chronically infected
mice exhibit increased expression of programmed
death 1 (PD-1) compared to memory CD8+ T cells after
acute LCMV infection. Interestingly, PD-1 is relevant
for maintaining the dysfunction of memory cells in
chronically infected mice because blocking the interac-
tion with its ligand, PD-1L, enhances viral control, in-
creases CD8+ T cell function (cytokine production andcytotoxicity), and restores proliferation in response to
viral Ag (Barber et al., 2006). Although this study (Barber
et al., 2006) suggests possible strategies to facilitate vi-
ral control during chronic infections, it is not well under-
stood why CD8+ T cells that develop during prolonged
exposure to Ag (pathogen) never attain all of the pheno-
typic and functional hallmarks of ‘‘good’’ memory cells.
Given the evidence that inflammation regulates the rate
at which CD8+ T cells acquire memory characteristics,
it is perhaps not surprising that dysfunction of CD8+
T cells in at least some mouse and human chronic infec-
tions (e.g., HIV, HBV, and Trypanosoma cruzi) also cor-
relates with persistent inflammation (Decrion et al.,
2005; Leavey and Tarleton, 2003; Maini et al., 2000).
Summary and Future Directions
In addition to their role in stimulating antimicrobial de-
fenses and the Ag-presenting capacity of host APCs, in-
flammatory cytokines act directly on responding T cells
to affect all phases of the T cell response to infection.
Depending on the pathogen, and likely on the adjuvant
chosen for vaccination, signals from one or more inflam-
matory cytokines are required for proliferation and sur-
vival of the responding T cells, so that optimal expansion
in effector T cell numbers can occur to defend against
infection. Somewhat paradoxically, at least one of the
inflammatory cytokines (IFN-g) required for optimal T
cell expansion also ensures the appropriate contraction
in numbers of Ag-specific T cells. Finally, inflammation
regulates (delays) the rate at which Ag-specific CD8+
T cells acquire important memory characteristics after
infection and vaccination. Together, these data suggest
that the type, magnitude, and duration of inflammation
allow the responding T cells to sense the degree of
‘‘danger’’ associated with a specific Ag encounter and,
in response, to potentially modify their expansion and
contraction and maintain heightened immunity by delay-
ing their transition from an effector population.
Clearly, strong adjuvants that elicit inflammation and
provide signals to mature DCs improve the magnitude
of the T cell response against nonreplicating vaccine
agents. However, by mimicking infection, adjuvant-in-
duced inflammation also causes substantial contraction
and delays the acquisition of memory characteristics,
including the ability to respond to booster immunization,
by the responding T cell populations. An ideal vaccine
may in fact evoke modest expansion in Ag-specific
CD8+ T cell numbers but rapid progression to memory
with limited contraction, thus reducing the interval be-
tween initial priming and booster immunizations required
for optimally protective secondary memory responses.
The challenge will be devising vaccination regimens
that promote DC maturation while limiting exposure of
the responding T cells to inflammatory cytokines. Exist-
ing and emerging mouse models of infection, in combina-
tion with the ability to correlate phenotype with function
of Ag-specific T cells, provide high-resolution systems
to test these ideas in the context of vaccination. In addi-
tion, the most interesting future studies will address the
mechanisms by which inflammatory cytokine signals de-
livered to Ag-specific CD8+ T cells within hours of their
initial stimulation can control the fate of these cells after
many subsequent cell divisions.
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